精活速治疗少弱精子症疗效观察

发布时间：2018-07-03 20:13

本文选题：精活速 + 男性不育　；参考：《中华男科学杂志》2017年03期

【摘要】：目的:探讨精活速治疗少弱精子症的有效性。方法:120例特发性轻中度少、弱精子症患者入选本研究;口服精活速,1袋/次,2次/d,连续3个月;分别于治疗前及治疗后第1、2、3个月末,采用计算机辅助精液分析检测治疗前后每次射精后精液的各项参数变化(精子浓度、精子总活力、前向运动精子百分率、正常形态精子百分率),每次随访均记录患者有无明显不良反应。结果:治疗3个月后,入组患者的精液质量有了较明显的改善。精液中精子浓度、精子总活动率、前向运动精子百分率和精子形态正常百分率,在服用精活速治疗3个月后均有了较明显的改善(P0.05),观察的3个月期间内,未见明显不良反应。结论:精活速治疗轻中度少弱精子症患者症疗效显著,无明显不良反应。
[Abstract]:Objective: to investigate the efficacy of spermatogonium in the treatment of oligoasthenospermia. Methods 120 patients with idiopathic mild to moderate hypozoospermia were enrolled in this study. The changes of semen parameters (sperm concentration, total sperm motility, percentage of forward motile sperm) before and after treatment were measured by computer-aided semen analysis. Percentage of normal sperm morphology), each follow-up recorded whether the patient had significant adverse reactions. Results: after 3 months of treatment, the semen quality of the patients in the group improved significantly. Sperm concentration, total motility rate, forward motility sperm percentage and normal sperm morphology were significantly improved after 3 months of spermatozoa treatment (P0.05), and no significant adverse reactions were observed during the observed 3 months. Conclusion: the effect of spermatogonium on mild to moderate oligozoospermia is significant, and there is no obvious adverse reaction.
【作者单位】：北京大学第三医院生殖男科;南京军区南京总医院男科;上海交通大学附属仁济医院泌尿外科;第二军医大学附属长海医院泌尿外科;华中科技大学附属同济医院泌尿外科;同济大学附属同济医院泌尿外科;上海中医药大学附属龙华医院泌尿外科;北京大学第三医院泌尿外科;
【分类号】：R698.2

【相似文献】